contents

business
 
editorial
news
press room
press service
information
trade fairs
classifieds
useful links

BV2 joins SNC-Lavalin in Europe

SNC-Lavalin, Canada s biggest engineering and construction company, announced that BV2, a key player in pharmaceutical and biotechnology engineering in the Benelux countries, is joining SNC-Lavalin in Europe. This Belgian firm, headquartered in Onze-Lieve-Vrouw-Waver, near Mechelen, north of Brussels, has 63 employees.

By joining SNC-Lavalin, an international leader in engineering and construction, and particularly SNC-Lavalin Pharma, its subsidiary specializing in fine chemicals and pharmaceutical and biotechnology products, BV2 can now rely on an international network of 800 pharmaceutical and biotechnology industry experts, including 240 in Europe, and be part of a specialized group of European and international centres of competence. Through this acquisition, SNC Lavalin Pharma is consolidating its presence in the Benelux countries.



write your comments about the article :: © 2009 Construction News :: home page